Skip to main content
logo
Poolbeg Pharma PLC (AIM:POLB)
London flag London · Delayed Price · Currency is GBP · Price in GBX
8.50
-0.20 (-2.30%)
Aug 14, 2026, 4:35 PM GMT

Poolbeg Pharma Balance Sheet

Millions GBP. Fiscal year is Jan - Dec.

Assets

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
7.717.8212.1716.1920.95
Cash & Short-Term Investments
7.717.8212.1716.1920.95
Cash Growth
-1.42%-35.72%-24.84%-22.70%-
Accounts Receivable
0.070.02--0.01
Other Receivables
0.220.250.660.080.05
Receivables
0.290.270.660.080.06
Prepaid Expenses
0.270.470.670.880.45
Total Current Assets
8.278.5613.517.1621.46
Other Intangible Assets
1.671.681.932.131.56
Total Assets
9.9410.2515.4319.2923.02

Liabilities

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
0.150.170.080.290.08
Accrued Expenses
1.180.790.90.670.36
Other Current Liabilities
0.010.020.0100
Total Current Liabilities
1.340.970.990.970.44
Total Liabilities
1.340.970.990.970.44

Shareholders' Equity

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
0.140.10.10.10.1
Additional Paid-In Capital
27.5423.123.123.123.1
Retained Earnings
-22.44-16.74-10.95-7.02-2.34
Comprehensive Income & Other
3.362.822.22.151.72
Shareholders' Equity
8.69.2714.4418.3222.58
Total Liabilities & Equity
9.9410.2515.4319.2923.02

Additional Metrics

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Cash (Debt)
7.717.8212.1716.1920.95
Net Cash Growth
-1.42%-35.72%-24.84%-22.70%-
Net Cash Per Share
0.010.020.020.030.07
Filing Date Shares Outstanding
705.1500500500500
Total Common Shares Outstanding
697.2500500500500
Working Capital
6.937.5912.5116.1921.02
Book Value Per Share
0.010.020.030.040.05
Tangible Book Value
6.937.5912.5116.1921.02
Tangible Book Value Per Share
0.010.020.030.030.04